Current Problems in Surgery
Volume 45, Issue 12 , Pages 844-899 , December 2008

Thromboembolic Diseases

  • Thomas W. Wakefield, MD, FACS

      Affiliations

    • S. Martin Lindenauer Professor of Surgery, Section Head of Vascular Surgery, University of Michigan, Ann Arbor, Michigan
    • ,
  • Joseph Caprini, MD

      Affiliations

    • Professor of Surgery, Northwestern University Feinberg School of Medicine, Professor of Biomedical Engineering, Northwestern University, Evanston, Illinois
    • ,
  • Anthony J. Comerota, MD, FACS, FACC

      Affiliations

    • Director of the Jobst Vascular Center, Toledo, Ohio

References 

  1. Heit JA, Cohen AT, Anderson FJ. Estimated annual number of incident and recurrent, non-fatal venous thromboembolism (VTE) events in the US. Blood. 2005;106
  2. Prandoni P, Lensing AW, Prins MR. Long-term outcomes after deep venous thrombosis of the lower extremities. Vasc Med. 1998;3:57–60
  3. Bauer KA, Rosendaal FR, Heit JA. Hypercoagulability: too many tests, too much conflicting data. Hematology Am Soc Hematol Educ Program. 2002;353–368
  4. Henke P. Vascular thrombosis due to hypercoagulable states. In: Rutherford's Textbook of Vascular Surgery. 6th ed.. Philadelphia, PA: Elsevier Saunders; 2004;p. 568–578
  5. Andreotti F, Becker RC. Atherothrombotic disorders: new insights from hematology. Circulation. 2005;111:1855–1863
  6. Stewart GJ. Neutrophils and deep venous thrombosis. Haemostasis. 1993;23(suppl 1):127–140
  7. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008;28:387–391
  8. Myers DD, Schaub R, Wrobleski SK, Londy FJ, Fex BA, Chapman AM, et al. P-selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb Haemost. 2001;85:423–429
  9. Myers D, Wrobleski S, Londy F, Fex B, Hawley A, Schaub R, et al. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig. Thromb Haemost. 2002;87:374–382
  10. Day SM, Reeve JL, Pedersen B, Farris DM, Myers DD, Im M, et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood. 2005;105:192–198
  11. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349:1227–1235
  12. Perkins JM, Magee TR, Galland RB. Phlegmasia caerulea dolens and venous gangrene. Br J Surg. 1996;83:19–23
  13. Fowl RJ, Strothman GB, Blebea J, Rosenthal GJ, Kempczinski RF. Inappropriate use of venous duplex scans: an analysis of indications and results. J Vasc Surg. 1996;23:881–885discussion 885-6.
  14. Douglas MG, Sumner DS. Duplex scanning for deep vein thrombosis: has it replaced both phlebography and noninvasive testing?. Semin Vasc Surg. 1996;9:3–12
  15. Guyatt GH, Cook DJ, Jaeschke R, Pauker SG, Schünemann HJ. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008;133:123S–131S(8th ed).
  16. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354:2317–2327
  17. Schellong SM, Schwarz T, Halbritter K, Beyer J, Siegert G, Oettler W, et al. Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis. Thromb Haemost. 2003;89:228–234
  18. Cornuz J, Ghali WA, Hayoz D, Stoianov R, Depairon M, Yersin B. Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative D-dimer testing. Am J Med. 2002;112:198–203
  19. Rectenwald JE, Myers DD, Hawley AE, Longo C, Henke PK, Guire KE, et al. D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis (A pilot study). Thromb Haemost. 2005;94:1312–1317
  20. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism (Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED)). JAMA. 1990;263:2753–2759
  21. Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED Study (Prospective Investigation of Pulmonary Embolism Diagnosis Study). J Nucl Med. 1995;36:2380–2387
  22. Remy-Jardin M, Remy J. Spiral CT angiography of the pulmonary circulation. Radiology. 1999;212:615–636
  23. Prandoni P, Bernardi E. Upper extremity deep vein thrombosis. Curr Opin Pulm Med. 1999;5:222–226
  24. Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med. 1997;157:2562–2568
  25. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458–462
  26. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7
  27. Bates SM, Ginsberg JS. Clinical practice (Treatment of deep-vein thrombosis). N Engl J Med. 2004;351:268–277
  28. van Den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2008;3:CD001100
  29. Ageno W, Turpie AG. Low-molecular-weight heparin in the treatment of pulmonary embolism. Semin Vasc Surg. 2000;13:189–193
  30. Hull RD, Pineo GF, Mah AF, Brant R. A randomized trial evaluating long-term low-molecular-weight heparin therapy out-of-hospital versus warfarin sodium comparing the post-phlebotic outcomes at three months. Blood. 2001;98:447A
  31. van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev. 2004;4:CD001100
  32. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119(1 suppl):176S–193S
  33. Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137:955–960
  34. Hull RD, Marder VJ, Mah AF, Biel RK, Brant RF. Quantitative assessment of thrombus burden predicts the outcome of treatment for venous thrombosis: a systematic review. Am J Med. 2005;118:456–464
  35. Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost. 2005;94:969–974
  36. Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med. 2006;355:1780–1789
  37. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003;348:1425–1434
  38. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med. 2003;349:631–639
  39. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med. 2003;139:893–900
  40. Almeida JI, Coats R, Liem TK, Silver D. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome. J Vasc Surg. 1998;27:309–314discussion 315-16.
  41. Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb Haemost. 1992;67:545–549
  42. Alving BM. How I treat heparin-induced thrombocytopenia and thrombosis. Blood. 2003;101:31–37
  43. Baldwin ZK, Spitzer AL, Ng VL, Harken AH. Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT). Surgery. 2008;143:305–312
  44. Greinacher A, Volpel H, Janssens U, Hach-Wunderle V, Kemkes-Matthes B, Eichler P, et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation. 1999;99:73–80
  45. Kovacs MJ. Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux. Thromb Haemost. 2005;93:999–1000
  46. Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146–153
  47. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975–980
  48. van Dongen CJ. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. Cochrane Database Syst Rev. 2006;3:CD003074
  49. Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med. 2001;134:191–202
  50. Gross PL, Weitz JI. New anticoagulants for treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol. 2008;28:380–386
  51. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002;162:1833–1840
  52. Wolozinsky M, Yavin YY, Cohen AT. Pharmacological prevention of venous thromboembolism in medical patients at risk. Am J Cardiovasc Drugs. 2005;5:409–415
  53. Agnelli G, Bergqvist D, Cohen AT, Gallus AS, Gent M. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surg. 2005;92:1212–1220
  54. Eriksson BI, Lassen MR. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2003;163:1337–1342
  55. Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med. 2004;140:867–873
  56. Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349:1695–1702
  57. Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, et al. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med. 2007;357:1094–1104
  58. Spyropoulos AC. Investigational treatments of venous thromboembolism. Expert Opin Investig Drugs. 2007;16:431–440
  59. Agnelli G, Gallus A, Goldhaber SZ, Haas S, Huisman MV, Hull RD, et al. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. Circulation. 2007;116:180–187
  60. Weitz JI, Hirsh J, Samama MM. New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):265S–286S
  61. Saiah E, Soares C. Small molecule coagulation cascade inhibitors in the clinic. Curr Top Med Chem. 2005;5:1677–1695
  62. Greenfield LJ, Proctor MC. Twenty-year clinical experience with the Greenfield filter. Cardiovasc Surg. 1995;3:199–205
  63. Berry RE, George JE, Shaver WA. Free-floating deep venous thrombosis (A retrospective analysis). Ann Surg. 1990;211:719–722discussion 722-3.
  64. Langan EM, Miller RS, Casey WJ, Carsten CG, Graham RM, Taylor SM. Prophylactic inferior vena cava filters in trauma patients at high risk: follow-up examination and risk/benefit assessment. J Vasc Surg. 1999;30:484–488
  65. Sugerman HJ, Sugerman EL, Wolfe L, Kellum JM, Schweitzer MA, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41–46
  66. Chiou AC. Beside placement of IVC filters. Endovasc Today. 2005;4:60–63
  67. Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group). N Engl J Med. 1998;338:409–415
  68. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141:249–256
  69. Aschwanden M, Labs KH, Engel H, Schwob A, Jeanneret C, Mueller-Brand J, et al. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost. 2001;85:42–46
  70. Partsch H. Ambulation and compression after deep vein thrombosis: dispelling myths. Semin Vasc Surg. 2005;18:148–152
  71. Henke P. Effect of venous thromboembolism on mortality costs, and length of stay in hospitalized medical patients. Circ. 2005;111:e322
  72. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611–1617
  73. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism (The Worcester DVT Study). Arch Intern Med. 1991;151:933–938
  74. Anderson FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT, Anderson FA, et al. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. [see comment] Am J Hematol. 2007;82:777–782
  75. Heit J, Cohen A, Anderson F. Estimated annual number of incident and recurrent non-fatal and fatal venous thromboembolism (VTE) events in the US. Blood. 1995;106:Abstract 910
  76. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of Venous Thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S–400S
  77. Pengo V, Lensing AWA, Prins MH, Marchiori A, Davidson BL, Tiozzo F, et al. Thromboembolic Pulmonary Hypertension Study Group (Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism). N Engl J Med. 2004;350:2257–2264
  78. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141:249–256
  79. Borow M, Goldson H. Postoperative venous thrombosis (Evaluation of five methods of treatment). Am J Surg. 1981;141:245–251
  80. Borow M, Goldson HJ. Prevention of postoperative deep venous thrombosis and pulmonary emboli with combined modalities. Am Surg. 1983;49:599–605
  81. Pesavento R, Bernardi E, Concolato A, Dalla Valle F, Pagnan A, Prandoni P. Postthrombotic syndrome. Semin Thromb Hemost. 2006;32:744–751
  82. Heit JA. Venous stasis syndrome: the long-term burden of deep vein thrombosis. Hosp Med. 2003;64:593–598
  83. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7
  84. Puggioni A, Kalra M, Gloviczki P. Practical aspects of the postthrombotic syndrome. Dis Mon. 2005;51:166–175
  85. Salinger MH, Feldman TE. Patent foramen ovale: the missing link between deep venous thrombotic disease and embolic stroke. Dis Mon. 2005;51:94–103
  86. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809–815
  87. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70–78
  88. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162:1245–1248
  89. Sugerman HJ, Sugerman EL, Wolfe L, Kellum JM, Schweitzer MA, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001;234:41–46
  90. Kroger K, Weiland D, Ose C, Neumann N, Weiss S, Hirsch C, et al. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol. 2006;17:297–303
  91. Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 suppl 1):I9–I16
  92. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA, et al. Prevention of venous thromboembolism. Chest. 2001;119(1 suppl):132S–175S
  93. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352:969–977
  94. Zakai NA, Wright J, Cushman M. Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score. J Thromb Haemost. 2004;2:2156–2161
  95. Kakkar VV. Prevention of fatal postoperative pulmonary embolism by low doses of heparin (An international multicentre trial). Lancet. 1975;2:45–51
  96. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin (Overview of results of randomized trials in general, orthopedic, and urologic surgery). N Engl J Med. 1988;318:1162–1173
  97. Geerts W. Antithrombotic and thrombolytic therapy (8th Ed: ACCP Guidelines). Chest. 2008;133:381S–451S
  98. Warkentin TE. Heparin-induced thrombocytopenia. Dis Mon. 2005;51:141–149
  99. Nurmohamed MT, Rosendaal FR, Buller HR, Dekker E, Hommes DW, Vandenbroucke JP, et al. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet. 1992;340:152–156
  100. Leizorovicz A, Haugh MC, Chapuis FR, Samama MM, Boissel JP. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ. 1992;305:913–920
  101. Bergqvist D. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Br J Surg. 2004;91:965–974
  102. Haas S, Wolf H, Kakkar AK, Fareed J, Encke A. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin. Thromb Haemost. 2005;94:814–819
  103. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, Nielsen JD, Horn A, Mohn AC, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4:2384–2390
  104. Turpie AG, Eriksson BI, Bauer KA, Lassen MR. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. Chest. 2003;124(6 suppl):371S–378S
  105. Sigel B, Edelstein AL, Felix WR, Memhardt CR. Compression of the deep venous system of the lower leg during inactive recumbency. Arch Surg. 1973;106:38–43
  106. Comerota AJ, Stewart GJ, Alburger PD, Smalley K, White JV. Operative venodilation: a previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery. 1989;106:301–308discussion 308-9.
  107. Coleridge-Smith PD, Hasty JH, Scurr JH. Venous stasis and vein lumen changes during surgery. Br J Surg. 1990;77:1055–1059
  108. Coleridge Smith PD, Hasty JH, Scurr JH. Deep vein thrombosis: effect of graduated compression stockings on distension of the deep veins of the calf. Br J Surg. 1991;78:724–726
  109. Wells PS, Lensing AW, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism (A meta-analysis). Arch Intern Med. 1994;154:67–72
  110. Amaragiri SV, Lees TA. Elastic compression stockings for the prevention of DVT. Cochrane Database Syst Rev. 2008;3:CD001484
  111. Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. Health Technol Assess. 2005;9:1–78
  112. Benko T, Cooke EA, McNally MA, Mollan RA. Graduated compression stockings: knee length or thigh length. Clin Orthop Rel Res. 2001;383:197–203
  113. Byrne B. Deep vein thrombosis prophylaxis: the effectiveness and implications of using below-knee or thigh-length graduated compression stockings. Heart Lung. 2001;30:277–284
  114. Kakkos SK, Griffin M, Geroulakos G, Nicolaides AN. The efficacy of a new portable sequential compression device (SCD Express) in preventing venous stasis. J Vasc Surg. 2005;42:296–303
  115. Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R, et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg. 1997;226:306–313discussion 313-4.
  116. Kessler CM, Hirsch DR, Jacobs H, MacDougall R, Goldhaber SZ. Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coagul Fibrinolysis. 1996;7:437–446
  117. Guyton DP, Khayat A, Husni EA, Schreiber H. Elevated levels of 6-keto-prostaglandin-F1a from a lower extremity during external pneumatic compression. Surg Gynecol Obstet. 1988;166:338–342
  118. Summaria L, Caprini JA, McMillan R, Sandesara J, Axelrod CA, Mueller ME, et al. Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg. 1988;54:156–160
  119. Urbankova J, Quiroz R, Kucher N, Goldhaber SZ. Intermittent pneumatic compression and deep vein thrombosis prevention (A meta-analysis in postoperative patients). Thromb Haemost. 2005;94:1181–1185
  120. Comerota AJ, Katz ML, White JV. Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail?. Am J Surg. 1992;164:265–268
  121. PEP. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) Trial. Lancet. 2000;355:1295–1302
  122. Wille-Jorgensen P, Rasmussen MS, Andersen BR, Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery. Cochrane Database Syst Rev. 2003;4:CD001217
  123. Borow M, Goldson H. Postoperative venous thrombosis (Evaluation of five methods of treatment). Am J Surg. 1981;141:245–251
  124. Woolson ST, Watt JM. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement (A prospective, randomized study of compression alone, compression and aspirin, and compression and low-dose warfarin). J Bone Joint Surg Am. 1991;73:507–512
  125. Bradley JG, Krugener GH, Jager HJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J Arthroplasty. 1993;8:57–61
  126. Ramos R, Salem BI, De Pawlikowski MP, Coordes C, Eisenberg S, Leidenfrost R. The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest. 1996;109:82–85
  127. Silbersack Y, Taute BM, Hein W, Podhaisky H. Prevention of deep-vein thrombosis after total hip and knee replacement (Low-molecular-weight heparin in combination with intermittent pneumatic compression). J Bone Joint Surg. 2004;86:809–812
  128. Eisele R, Kinzl L, Koelsch T. Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis. J Bone Joint Surg Am. 2007;89:1050–1056
  129. Westrich GH, Bottner F, Windsor RE, Laskin RS, Haas SB, Sculco TP. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty. 2006;21(6 suppl 2):139–143
  130. Turpie AG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007;5:1854–1861
  131. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost. 2007;5:1610–1616
  132. Caprini JA, Arcelus JI, Hoffman K, Mattern T, Laubach M, Size GP, et al. Prevention of venous thromboembolism in North America: results of a survey among general surgeons. J Vasc Surg. 1994;20:751–758
  133. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371:387–394
  134. Warwick D, Friedman R, Agnelli G, et al. Global orthopedic registry (GLORY). J Bone Joint Surg Br. 2007;89:1409
  135. Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med. 2002;162:1144–1148
  136. Kahn SR, Elman EA, Bornais C, Blostein M, Wells PS. Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost. 2005;93:499–502
  137. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg. 2004;239:118–126
  138. O'Donnell TF, Browse NL, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res. 1977;22:483–488
  139. Akesson H, Brudin L, Dahlstrom JA, Eklof B, Ohlin P, Plate G. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg. 1990;4:43–48
  140. Comerota AJ, Gravett MH. Iliofemoral venous thrombosis. J Vasc Surg. 2007;46:1065–1076
  141. Comerota AJ, Paolini D. Treatment of acute iliofemoral deep venous thrombosis: a strategy of thrombus removal. Eur J Vasc Endovasc Surg. 2007;33:351–360discussion 361-2.
  142. Shull KC, Nicolaides AN, Fernandes E, Fernandes J, Miles C, Horner J, et al. Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg. 1979;114:1304–1306
  143. Nicolaides A, Schull K, Fernandes E. Ambulatory venous pressure: new information. In:  Nicolaides AN,  Yao JS editor. Investigation of Vascular Disorders. New York: Churchill Livingston; 1981;p. 488–494
  144. Welkie JF, Comerota AJ, Katz ML, Aldridge SC, Kerr RP, White JV. Hemodynamic deterioration in chronic venous disease. J Vasc Surg. 1992;16:733–740
  145. Johnson BF, Manzo RA, Bergelin RO, Strandness DE. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg. 1995;21:307–312discussion 313.
  146. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg. 1993;18:596–605discussion 606-8.
  147. Cho JS, Martelli E, Mozes G, Miller VM, Gloviczki P. Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function. J Vasc Surg. 1998;28:787–799
  148. Rhodes JM, Cho JS, Gloviczki P, Mozes G, Rolle R, Miller VM. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg. 2000;31:1193–1205
  149. Johnson BF, Manzo RA, Bergelin RO, Strandness DEJ. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg. 1995;21:307–313
  150. Markel A, Manzo RA, Bergelin RO, Strandness DE. Valvular reflux after deep vein thrombosis: incidence and time of occurrence. J Vasc Surg. 1992;15:377–382discussion 383-4.
  151. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dietz CA, Caldwell MD, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405–418
  152. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39–49
  153. Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130–137
  154. Plate G, Einarsson E, Ohlin P, Jensen R, Qvarfordt P, Eklof B. Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg. 1984;1:867–876
  155. Plate G, Akesson H, Einarsson E, Ohlin P, Eklof B. Long-term results of venous thrombectomy combined with a temporary arterio-venous fistula. Eur J Vasc Surg. 1990;4:483–489
  156. Plate G, Eklof B, Norgren L, Ohlin P, Dahlstrom JA. Venous thrombectomy for iliofemoral vein thrombosis—10-year results of a prospective randomized study. Eur J Vasc Endovasc Surg. 1997;14:367–374
  157. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis (A randomised clinical trial). Eur J Vasc Endovasc Surg. 2002;24:209–214
  158. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic Therapy for Venous Thromboembolic Disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):401S–428S
  159. Martinez J, Comerota AJ. Chest and abdominopelvic CT scans are important tools for evaluating patients with iliofemoral venous thrombosis. PD J Vasc Surg. 2008;In press
  160. Plate G, Eklof B, Norgren L, Ohlin P, Dahlstrom JA. Venous thrombectomy for iliofemoral vein thrombosis—10-year results of a prospective randomised study. Eur J Vasc Endovasc Surg. 1997;14:367–374
  161. Eklof B, Juhan C. Revival of thromboectomy in the management of acute iliofemoral venous thrombosis. Contemp Surg. 1992;40:21
  162. Piquet P. Traitement chirurgical des thromboses iliocaves: exigences et resultats. In:  Kieffer E editors. Chirurgie de la Veine Cave Inferieure et de Ses Branches. Paris: Expansion Scientifique Francaise; 1985;210-6
  163. Einarsson E, Albrechtsson U, Eklof B. Thrombectomy and temporary AV-fistula in iliofemoral vein thrombosis (Technical considerations and early results). Int Angiol. 1986;5:65–72
  164. Vollmar JF. Robert May Memorial Lecture: Advances in reconstructive venous surgery. Int Angiol. 1986;5:117–129
  165. Juhan C, Alimi Y, Di Mauro P, Hartung O. Surgical venous thrombectomy. Cardiovasc Surg. 1999;7:586–590
  166. Torngren S, Swedenborg J. Thrombectomy and temporary arterio-venous fistula for ilio-femoral venous thrombosis. Int Angiol. 1988;7:14–18
  167. Rasmussen A, Mogensen K, Nissen FH, Wadt J, Skibsted L. [Acute iliofemoral venous thrombosis. 26 cases treated with thrombectomy, temporary arteriovenous fistula and anticoagulants]. Ugeskr Laeger. 1990;152:2928–2930
  168. Eklof B, Kistner RL. Is there a role for thrombectomy in iliofemoral venous thrombosis?. Semin Vasc Surg. 1996;9:34–45
  169. Neglen P, al-Hassan HK, Endrys J, Nazzal MM, Christenson JT, Eklof B. Iliofemoral venous thrombectomy followed by percutaneous closure of the temporary arteriovenous fistula. Surgery. 1991;110:493–499
  170. Meissner AJ, Huszcza S. Surgical strategy for management of deep venous thrombosis of the lower extremities. World J Surg. 1996;20:1149–1155
  171. Pillny M, Sandmann W, Luther B, Muller BT, Tutschek B, Gerhardt A, et al. Deep venous thrombosis during pregnancy and after delivery: indications for and results of thrombectomy. J Vasc Surg. 2003;37:528–532
  172. Ganger KH, Nachbur BH, Ris HB, Zurbrugg H. Surgical thrombectomy versus conservative treatment for deep venous thrombosis; functional comparison of long-term results. Eur J Vasc Surg. 1989;3:529–538
  173. Kniemeyer HW, Sandmann W, Schwindt C, Grabitz K, Torsello G, Stuhmeier K. Thrombectomy with arteriovenous fistula for embolizing deep venous thrombosis: an alternative therapy for prevention of recurrent pulmonary embolism. The Clinical Investigator. 1993;72:40–45
  174. Comerota AJ, Gale SS. Technique of contemporary iliofemoral and infrainguinal venous thrombectomy. J Vasc Surg. 2006;43:185–191
  175. Comerota A, Gale SS. Operative venous thrombectomy. In:  Bergan JJ editors. The Vein Book. San Diego: Elsevier; 2006;p. 405–416
  176. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984;76:393–397
  177. Elliot MS, Immelman EJ, Jeffery P, Benatar SR, Funston MR, Smith JA, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66:838–843
  178. Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis (Follow-up results of a prospective study). Acta Med Scand. 1982;211:65–68
  179. Jeffery P, Immelman EJ, Moore J. Treatment of deep vein thrombosis with heparin or streptokinase: long-term venous function assessment. Proceedings of the Second International Vascular Symposium. 1989;Abstract N. S20.3.
  180. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology. 1994;191:487–494
  181. Semba CP, Dake MD. Catheter-directed thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg. 1996;9:26–33
  182. Verhaeghe R, Stockx L, Lacroix H, Vermylen J, Baert AL. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol. 1997;7:996–1001
  183. Horne MK, Mayo DJ, Cannon RO, Chen CC, Shawker TH, Chang R. Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities. Am J Med. 2000;108:251–255
  184. Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol. 2001;12:179–185
  185. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg. 2001;233:752–760
  186. Vedantham S, Vesely TM, Parti N, Darcy M, Hovsepian DM, Picus D. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol. 2002;13:1001–1008
  187. Castaneda F, Li R, Young K, Swischuk JL, Smouse B, Brady T. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. J Vasc Interv Radiol. 2002;13:577–580
  188. Grunwald MR, Hofmann LV. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol. 2004;15:347–352
  189. Laiho MK, Oinonen A, Sugano N, Harjola VP, Lehtola AL, Roth WD, et al. Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. Eur J Vasc Endovasc Surg. 2004;28:391–396
  190. Sillesen H, Just S, Jorgensen M, Baekgaard N. Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency. Eur J Vasc Endovasc Surg. 2005;30:556–562
  191. Jackson LS, Wang XJ, Dudrick SJ, Gersten GD. Catheter-directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis. Am J Surg. 2005;190:864–868
  192. Ogawa T, Hoshino S, Midorikawa H, Sato K. Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with acute proximal venous thrombosis of the leg. J Vasc Surg. 2005;42:940–944
  193. Kim HS, Patra A, Paxton BE, Khan J, Streiff MB. Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol. 2006;17:1099–1104
  194. Lin PH, Zhou W, Dardik A, Mussa F, Kougias P, Hedayati N, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg. 2006;192:782–788
  195. Protack CD, Bakken AM, Patel N, Saad WE, Waldman DL, Davies MG. Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg. 2007;45:992–997discussion 997.
  196. Goldenberg NA, Durham JD, Knapp-Clevenger R, Manco-Johnson MJ. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood. 2007;110:45–53
  197. Enden T, Sandvik L, Klow NE, Hafsahl G, Holme PA, Holmen LO, et al. Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis—the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial. (NCT00251771) Am Heart J. 2007;154:808–814
  198. Vedantham S, Vesely TM, Parti N, Darcy M, Hovsepian DM, Picus D. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol. 2002;13:1001–1008
  199. Martinez JCA, Kazanjian S, DiSalle RS, Sepanski DM, Assi A. The quantitative benefit of isolated, segmental, pharmacomechanical thrombolysis for iliofemoral DVT. J Vasc Surg. 2008;In press
  200. Parikh S, Motarjeme A, McNamara T, Raabe R, Hagspiel K, Benenati JF, et al. Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience. J Vasc Interv Radiol. 2008;19:521–528
  201. Kearon C, Kahn SR, Agnelli G, Goldhaber SZ, Raskob G, Comerota AJ. Antithrombotic Therapy for Venous Thromboembolic Disease: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2008;133(6 Suppl):454S–545S(8th ed).
  202. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993;341:507–511
  203. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J. 1997;134:479–487
  204. Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation. 2002;105:1416–1419
  205. Yalamanchili K, Fleisher AG, Lehrman SG, Axelrod HI, Lafaro RJ, Sarabu MR, et al. Open pulmonary embolectomy for treatment of major pulmonary embolism. Ann Thorac Surg. 2004;77:819–823discussion 823.
  206. Agnelli G, Becattini C, Kirschstein T. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med. 2002;162:2537–2541
  207. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347:1143–1150
  208. The urokinase pulmonary embolism trial. A national cooperative study. Circulation. 1973;47(2 suppl):1–108
  209. Dong B, Jirong Y, Liu G, Wang Q, Wu T. Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev. 2006;2:CD004437
  210. Wan S, Quinlan DJ, Agnelli G, Eikelboom JW. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation. 2004;110:744–749
  211. Dalla-Volta S, Palla A, Santolicandro A, Giuntini C, Pengo V, Visioli O, et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism (Plasminogen activator Italian multicenter study 2). J Am Coll Cardiol. 1992;20:520–526
  212. Dotter C, Seaman AJ, Rosch J, Porter J. Streptokinase and heparin in the treatment of pulmonary embolism: a randomized comparison. Vasc Endovascular Surg. 1979;13:42–52
  213. Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis. 1995;2:227–229
  214. Ly B, Arnesen H, Eie H, Hol R. A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism. Acta Med Scand. 1978;203:465–470
  215. Tibbutt DA, Davies JA, Anderson JA, Fletcher EW, Hamill J, Holt JM, et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. BMJ. 1974;1:343–347
  216. Tissue plasminogen activator for the treatment of acute pulmonary embolism (A collaborative study by the PIOPED Investigators). Chest. 1990;97:528–533
  217. Urokinase Pulmonary Embolism Trial Study Group. Urokinase pulmonary embolism trial: phase I result. JAMA. 1970;214:2163–2172
  218. Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser K, Rauber K, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation. 1997;96:882–888
  219. Greenfield LJ, Bruce TA, Nichols NB. Transvenous pulmonary embolectomy by catheter device. Ann Surg. 1971;174:881–886
  220. Scoggins WG, Greenfield LJ. Transvenous pulmonary embolectomy for acute massive pulmonary embolism. Chest. 1977;71:213–216
  221. Greenfield LJ, Zocco JJ. Intraluminal management of acute massive pulmonary thromboembolism. J Thorac Cardiovasc Surg. 1979;77:402–410
  222. Moore JH, Koolpe HA, Carabasi RA, Yang SL, Jarrell BE. Transvenous catheter pulmonary embolectomy. Arch Surg. 1985;120:1372–1375
  223. Nakasaki Y, Tsujiyama S, Higo M, Yamamoto M, Yamashina H, Fujii T, et al. [A case of acute massive pulmonary embolism successfully treated with transvenous pulmonary embolectomy by catheter]. Kokyu to junkan. 1989;37:1363–1366
  224. Timsit JF, Reynaud P, Meyer G, Sors H. Pulmonary embolectomy by catheter device in massive pulmonary embolism. Chest. 1991;100:655–658
  225. Greenfield LJ, Proctor MC, Williams DM, Wakefield TW. Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg. 1993;18:450–457discussion 457-8.
  226. Hiramatsu S, Ogihara A, Kitano Y, Mashiko M, Iseki S, Muramatsu J, et al. [Clinical outcome of catheter fragmentation and aspiration therapy in patients with acute pulmonary embolism]. J Cardiol. 1999;34:71–78
  227. Tajima H, Murata S, Kumazaki T, Nakazawa K, Kawamata H, Fukunaga T, et al. Manual aspiration thrombectomy with a standard PTCA guiding catheter for treatment of acute massive pulmonary thromboembolism. Radiat Med. 2004;22:168–172
  228. Koning R, Cribier A, Gerber L, Eltchaninoff H, Tron C, Gupta V, et al. A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy. Circulation. 1997;96:2498–2500
  229. Voigtlander T, Rupprecht HJ, Nowak B, Post F, Mayer E, Stahr P, et al. Clinical application of a new rheolytic thrombectomy catheter system for massive pulmonary embolism. Catheter Cardiovasc Interv. 1999;47:91–96
  230. Zeni PT, Blank BG, Peeler DW. Use of rheolytic thrombectomy in treatment of acute massive pulmonary embolism. J Vasc Interv Radiol. 2003;14:1511–1515
  231. Chiam P, Kwok V, Johan BA, Chan C. Major pulmonary embolism treated with a rheolytic thrombectomy catheter. Singapore Med J. 2005;46:479–482
  232. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Zabakis P, et al. AngioJet rheolytic thrombectomy versus local intrapulmonary thrombolysis in massive pulmonary embolism: a retrospective data analysis. J Endovasc Ther. 2005;12:206–214
  233. Chauhan MS, Kawamura A. Percutaneous rheolytic thrombectomy for large pulmonary embolism: a promising treatment option. Catheter Cardiovasc Interv. 2007;70:121–128
  234. Margheri M, Vittori G, Vecchio S, Chechi T, Falchetti E, et al. Early and long-term clinical results of AngioJet rheolytic thrombectomy in patients with acute pulmonary embolism. Am J Cardiol. 2008;101:252–258
  235. Brady AJ, Crake T, Oakley CM. Percutaneous catheter fragmentation and distal dispersion of proximal pulmonary embolus. Lancet. 1991;338:1186–1189
  236. Sigmund M, Rubart M, Vom Dahl J, Uebis R, Hanrath P. Successful treatment of massive pulmonary embolism by combined mechanical and thrombolytic therapy. J Interv Cardiol. 1991;4:63–68
  237. Rafique M, Middlemost S, Skoularigis J, Sareli P. Simultaneous mechanical clot fragmentation and pharmacologic thrombolysis in acute massive pulmonary embolism. Am J Cardiol. 1992;69:427–430
  238. Manthey J, Frohlich G, Mautner JP, Munderloh KH, Zimmermann R. [Mechanical recanalization and local thrombolysis in a patient with fulminant pulmonary embolism and craniocerebral trauma]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1994;29:446–449
  239. Fava M, Loyola S, Flores P, Huete I. Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vasc Interv Radiol. 1997;8:261–266
  240. Stock KW, Jacob AL, Schnabel KJ, Bongartz G, Steinbrich W. Massive pulmonary embolism: treatment with thrombus fragmentation and local fibrinolysis with recombinant human-tissue plasminogen activator. Cardiovasc Intervent Radiol. 1997;20:364–368
  241. Schmitz-Rode T, Janssens U, Schild HH, Basche S, Hanrath P, Gunther RW. Fragmentation of massive pulmonary embolism using a pigtail rotation catheter. Chest. 1998;114:1427–1436
  242. Wong PS, Singh SP, Watson RD, Lip GY. Management of pulmonary thrombo-embolism using catheter manipulation: a report of four cases and review of the literature. Postgrad Med J. 1999;75:737–741
  243. Murphy JM, Mulvihill N, Mulcahy D, Foley B, Smiddy P, Molloy MP. Percutaneous catheter and guidewire fragmentation with local administration of recombinant tissue plasminogen activator as a treatment for massive pulmonary embolism. Eur Radiol. 1999;9:959–964
  244. Schmitz-Rode T, Janssens U, Duda SH, Erley CM, Gunther RW. Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter. J Am Coll Cardiol. 2000;36:375–380
  245. Schmitz-Rode T, Janssens U, Hanrath P, Gunther RW. Fragmentation of massive pulmonary embolism by pigtail rotation catheter: possible complication. Eur Radiol. 2001;11:2047–2049
  246. Prokubovski VI, Kapranov SA, Bobrov B. Endovascular rotary fragmentation in the treatment of massive pulmonary thromboembolism. Angiol Vasc Surg. 2003;9:31–39
  247. Tajima H, Murata S, Kumazaki T, Nakazawa K, Abe Y, Komada Y, et al. Treatment of acute massive pulmonary thromboembolism: mechanical fragmentation with a modified rotating pigtail catheter, local fibrinolytic therapy, and clot aspiration followed by systemic fibrinolytic therapy. AJR Am J Roentgenol. 2004;183:589–595
  248. De Gregorio MA, Gimeno MJ, Mainar A, Herrera M, Tobio R, Alfonso R, et al. Mechanical and enzymatic thrombolysis for massive pulmonary embolism. J Vasc Interv Radiol. 2002;13(2 pt 1):163–169
  249. Uflacker R, Strange C, Vujic I. Massive pulmonary embolism: preliminary results of treatment with the Amplatz thrombectomy device. J Vasc Interv Radiol. 1996;7:519–528
  250. Peuster M, Bertram H, Windhagen-Mahnert B, Paul T, Hausdorf G. [Mechanical recanalization of venous thrombosis and pulmonary embolism with the Clotbuster thrombectomy system in a 12-year-old boy]. Z Kardiol. 1998;87:283–287
  251. Muller-Hulsbeck S, Brossmann J, Jahnke T, Grimm J, Reuter M, Bewig B, et al. Mechanical thrombectomy of major and massive pulmonary embolism with use of the Amplatz thrombectomy device. Invest Radiol. 2001;36:317–322
  252. Michalis LK, Tsetis DK, Rees MR. Case report: percutaneous removal of pulmonary artery thrombus in a patient with massive pulmonary embolism using the hydrolyser catheter: the first human experience. Clin Radiol. 1997;52:158–161
  253. Fava M, Loyola S, Huete I. Massive pulmonary embolism: treatment with the hydrolyser thrombectomy catheter. J Vasc Interv Radiol. 2000;11:1159–1164
  254. Reekers JA, Baarslag HJ, Koolen MG, Van Delden O, van Beek EJ. Mechanical thrombectomy for early treatment of massive pulmonary embolism. Cardiovasc Intervent Radiol. 2003;26:246–250
  255. Rocek M, Peregrin J, Velimsky T. Mechanical thrombectomy of massive pulmonary embolism using an Arrow-Trerotola percutaneous thrombolytic device. Eur Radiol. 1998;8:1683–1685
  256. Lang EV, Barnhart WH, Walton DL, Raab SS. Percutaneous pulmonary thrombectomy. J Vasc Interv Radiol. 1997;8:427–432

PII: S0011-3840(08)00126-3

doi: 10.1067/j.cpsurg.2008.08.002

Current Problems in Surgery
Volume 45, Issue 12 , Pages 844-899 , December 2008

Article Tools

* Image Usage & Resolution